Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1979 Oct;190(4):474–486. doi: 10.1097/00000658-197910000-00007

Thoracic Duct Fistula and Renal Transplantation

Thomas E Starzl, Richard Weil III, Lawrence J Koep, Robert T McCalmon Jr, Paul I Terasaki, Yuichi Iwaki, Gerhard P J Schröter, John J Franks, Vibart Subryan, Charles G Halgrimson
PMCID: PMC1344512  PMID: 384943

Abstract

Thoracic duct drainage (TDD) was established for 21-115 days in 40 kidney recipients with an average removal per patient day of 4.7 1 lymph and 1.88 billion cells. Cellular and humoral immunity were depressed. TDD and immunosuppressive drugs were started at transplantation in 35 recipients of cross-match negative grafts. Although the results were better than in precedent non-TDD controls, eight patients rejected their grafts before a full TDD effect, and three of the eight developed predominantly anti-B lymphocyte cytotoxic antibodies which were probably responsible for positive cross-matches with their next donors. With continuing TDD, all eight patients had good initial function after early retransplantation. In five more “nontransplantable” patients with performed cytotoxic antibodies, TDD was started 30-56 days before transplantation. In these five pretreated patients, antibodies persisted with positive antidonor cross-matches. Hyperacute rejection occurred repeatedly in two patients with high anti-T (and anti-B) titers, but was surmounted in three patients with lower titers. From the clinical and immunologic data, we have concluded that TDD should be used for pretreatment of all cases with or without prior antibodies, and have suggested an adjustable management plan that takes into account new developments in antibody monitoring.

Full text

PDF
474

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archimbaud J. P., Banssillon V., Banssillon G., Bernhardt J. P., Revillard J. P., Perrin J., Traeger J., Carraz M., Fries D., Saubier E. C. Technique, surveillance et intérêt du drainage du canal thoracique, effectué en vue d'une transplantation rénale. J Chir (Paris) 1969 Sep;98(3):211–230. [PubMed] [Google Scholar]
  2. Ascher N. L., Ahrenholz D. H., Simmons R. L., Najarian J. S. 100 second renal allografts from a single transplantation institution. Transplantation. 1979 Jan;27(1):30–34. doi: 10.1097/00007890-197901000-00008. [DOI] [PubMed] [Google Scholar]
  3. Bentwich Z., Kunkel H. G. Specific properties of human B and T lymphocytes and alterations in disease. Transplant Rev. 1973;16:29–50. doi: 10.1111/j.1600-065x.1973.tb00116.x. [DOI] [PubMed] [Google Scholar]
  4. DUMONT A. E., MAYER D. J., MULHOLLAND J. H. THE SUPPRESSION OF IMMUNOLOGIC ACTIVITY BY DIVERSION OF THORACIC DUCT LYMPH. Ann Surg. 1964 Sep;160:373–383. doi: 10.1097/00000658-196409000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Estevam Ianhez L., Verginelli G., Sabbaga E., Campos Freire J. G. Thoracic duct drainage in human kidney allotransplantation. Rev Bras Pesqui Med Biol. 1974 May-Jun;7(3):265–272. [PubMed] [Google Scholar]
  6. Ettinger R. B., Terasaki P. I., Opelz G., Malekzadeh M., Uittenbogaart C., Pennisi A. J., Fine R. Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet. 1976 Jul 10;2(7976):56–58. doi: 10.1016/s0140-6736(76)92282-0. [DOI] [PubMed] [Google Scholar]
  7. Fish J. C., Sarles H. E., Tyson K. R., Remmers A. R., Jr, Ritzmann S. E. The immunologic consequences of lymph lymphocyte depletion. Surg Forum. 1969;20:268–269. [PubMed] [Google Scholar]
  8. Franksson C., Lundgren G., Magnusson G., Ringdén O. Drainage of thoracic duct lymph in renal transplant patients. Transplantation. 1976 Feb;21(2):133–140. doi: 10.1097/00007890-197602000-00008. [DOI] [PubMed] [Google Scholar]
  9. GOWANS J. L. The recirculation of lymphocytes from blood to lymph in the rat. J Physiol. 1959 Apr 23;146(1):54–69. doi: 10.1113/jphysiol.1959.sp006177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Graber C. D., Fitts C. T., Williams A. V., Artz C. P., Hargest T. S. Immunologic competence in the lymph-dialyzed patient. Surg Gynecol Obstet. 1969 Jan;128(1):1–7. [PubMed] [Google Scholar]
  11. HUME D. M., MAGEE J. H., KAUFFMAN H. M., Jr, RITTENBURY M. S., PROUT G. R., Jr RENAL HOMOTRANSPLANTATION IN MAN IN MODIFIED RECIPIENTS. Ann Surg. 1963 Oct;158:608–644. doi: 10.1097/00000658-196310000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hume D. M., Lee H. M., Williams G. M., White H. J., Ferré J., Wolf J. S., Prout G. R., Jr, Slapak M., O'Brien J., Kilpatrick S. J. Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg. 1966 Sep;164(3):352–397. doi: 10.1097/00000658-196609000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Husberg B. S., Starzl T. E. Proceedings: The outcome of kidney retransplantation. Arch Surg. 1974 Apr;108(4):584–587. doi: 10.1001/archsurg.1974.01350280184030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Iwaki Y., Terasaki P. I., Park M. S., Billing R. Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet. 1978 Jun 10;1(8076):1228–1229. doi: 10.1016/s0140-6736(78)92464-9. [DOI] [PubMed] [Google Scholar]
  15. Iwaki Y., Terasaki P. I., Weil R., Koep L., Starzl T. Retrospective tests of B-cold lymphocytotoxins and transplant survival at a single center. Transplant Proc. 1979 Mar;11(1):941–943. [PMC free article] [PubMed] [Google Scholar]
  16. Johnson H. K., Niblack G. D., Tallent M. B., Richie R. E. Immunologic preparation for cadaver renal transplant by thoracic duct drainage. Transplant Proc. 1977 Sep;9(3):1499–1503. [PubMed] [Google Scholar]
  17. Lobo P. I., Westervelt F. B., Jr, Rudolf L. Kidney transplantation across positive B and T cell crossmatches. Transplantation. 1978 Aug;26(2):84–86. doi: 10.1097/00007890-197808000-00004. [DOI] [PubMed] [Google Scholar]
  18. MCGREGOR D. D., GOWANS J. L. SURVIVAL OF HOMOGRAFTS OF SKIN IN RATS DEPLETED OF LYMPHOCYTES BY CHRONIC DRAINAGE FROM THE THORACIC DUCT. Lancet. 1964 Mar 21;1(7334):629–632. doi: 10.1016/s0140-6736(64)91451-5. [DOI] [PubMed] [Google Scholar]
  19. MURRAY J. E., MERRILL J. P., HARRISON J. H., WILSON R. E., DAMMIN G. J. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med. 1963 Jun 13;268:1315–1323. doi: 10.1056/NEJM196306132682401. [DOI] [PubMed] [Google Scholar]
  20. Machleder H. I., Paulus H. Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage. Surgery. 1978 Jul;84(1):157–165. [PubMed] [Google Scholar]
  21. McGregor D. D., Gowans J. L. THE ANTIBODY RESPONSE OF RATS DEPLETED OF LYMPHOCYTES BY CHRONIC DRAINAGE FROM THE THORACIC DUCT. J Exp Med. 1963 Jan 31;117(2):303–320. doi: 10.1084/jem.117.2.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Morris P. J., Ting A., Oliver D. Renal transplantation in the presence of a positive crossmatch. Transplant Proc. 1978 Jun;10(2):467–469. [PubMed] [Google Scholar]
  23. Murray J. E., Wilson R. E., Tilney N. L., Merrill J. P., Cooper W. C., Birtch A. G., Carpenter C. B., Hager E. B., Dammin G. J., Harrison J. H. Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg. 1968 Sep;168(3):416–435. doi: 10.1097/00000658-196809000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. NEWTON W. T. THE BIOLOGIC BASIS OF TISSUE TRANSPLANTATION. Surg Clin North Am. 1965 Apr;45:393–406. doi: 10.1016/s0039-6109(16)37539-9. [DOI] [PubMed] [Google Scholar]
  25. Najarian J. S., Simmons R. L., Condie R. M., Thompson E. J., Fryd D. S., Howard R. J., Matas A. J., Sutherland D. E., Ferguson R. M., Schmidtke J. R. Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg. 1976 Sep;184(3):352–368. doi: 10.1097/00000658-197609000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Niblack G. D., Johnson H. K., Richie R. E., Gonzalez L., Locke J., Jackson D. Preformed cytotoxic antibody in patients subjected to thoracic duct drainage. Proc Clin Dial Transplant Forum. 1975 Nov;5:146–150. [PubMed] [Google Scholar]
  27. Opelz G., Mickey M. R., Terasaki P. I. HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation. 1977 Jun;23(6):490–497. doi: 10.1097/00007890-197706000-00006. [DOI] [PubMed] [Google Scholar]
  28. Opelz G., Mickey M. R., Terasaki P. I. Identification of unresponsive kidney-transplant recipients. Lancet. 1972 Apr 22;1(7756):868–871. doi: 10.1016/s0140-6736(72)90739-8. [DOI] [PubMed] [Google Scholar]
  29. Opelz G., Sasaki N., Terasaki P. I. Prediction of long-term kidney transplant survival rates by monitoring early graft function and clinical grades. Transplantation. 1978 Apr;25(4):212–215. doi: 10.1097/00007890-197804000-00011. [DOI] [PubMed] [Google Scholar]
  30. Rabellino E., Colon S., Grey H. M., Unanue E. R. Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med. 1971 Jan 1;133(1):156–167. doi: 10.1084/jem.133.1.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. STARZL T. E., MARCHIORO T. L., WADDELL W. R. THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE. Surg Gynecol Obstet. 1963 Oct;117:385–395. [PMC free article] [PubMed] [Google Scholar]
  32. Sarles H. E., Remmers A. R., Jr, Fish J. C., Canales C. O., Thomas F. D., Tyson K. R., Beathard G. A., Ritzmann S. E. Depletion of lymphocytes for the protection of renal allografts. Arch Intern Med. 1970 Mar;125(3):443–450. [PubMed] [Google Scholar]
  33. Sommer B. G., Sutherland E. R., Simmons R. L., Howard R. J., Najarian J. S. Prognosis after renal transplantation: cumulative influence of combined risk factors. Transplantation. 1979 Jan;27(1):4–7. doi: 10.1097/00007890-197901000-00002. [DOI] [PubMed] [Google Scholar]
  34. Sonoda T., Takaha M., Kusunoki T. Prolonged thoracic duct lymph drainage. Application for human renal homotransplantation. Arch Surg. 1966 Nov;93(5):831–833. doi: 10.1001/archsurg.1966.01330050135020. [DOI] [PubMed] [Google Scholar]
  35. Starzl T. E., Koep L. J., Weil R., 3rd, Halgrimson C. G., Franks J. J. Thoracic duct drainage in organ transplantation: will it permit better immunosuppression? Transplant Proc. 1979 Mar;11(1):276–284. [PMC free article] [PubMed] [Google Scholar]
  36. Starzl T. E., Marchioro T. L., Porter K. A., Iwasaki Y., Cerilli G. J. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet. 1967 Feb;124(2):301–308. [PMC free article] [PubMed] [Google Scholar]
  37. Starzl T. E., Putnam C. W., Halgrimson C. G., Schroter G. T., Martineau G., Launois B., Corman J. L., Penn I., Booth A. S., Jr, Groth C. G. Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet. 1971 Dec;133(6):981–991. [PMC free article] [PubMed] [Google Scholar]
  38. Starzl T. E., Weil R., Putnam C. W. Kidney transplantation. Modern trends in kidney transplantation. Transplant Proc. 1977 Mar;9(1):1–8. [PMC free article] [PubMed] [Google Scholar]
  39. TUNNER W. S., CARBONE P. P., IRVING L., 3rd EFFECT OF THORACIC DUCT LYMPH DRAINAGE ON THE IMMUNE RESPONSE IN MAN. Surg Gynecol Obstet. 1965 Aug;121:334–338. [PubMed] [Google Scholar]
  40. Terasaki P. I., Bernoco D., Park M. S., Ozturk G., Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol. 1978 Feb;69(2):103–120. doi: 10.1093/ajcp/69.2.103. [DOI] [PubMed] [Google Scholar]
  41. Thomas F., Mendez-Picon G., Thomas J., Peace K., Flora R., Lee H. M. Effect of antilyphocyte-globulin potency on survival of cadaver renal transplants. Prospective randomised double-blind trial. Lancet. 1977 Oct 1;2(8040):671–674. doi: 10.1016/s0140-6736(77)90491-3. [DOI] [PubMed] [Google Scholar]
  42. Tilney N. L., Atkinson J. C., Murray J. E. The immunosuppressive effect of thoracic duct drainage in human kidney transplantation. Ann Intern Med. 1970 Jan;72(1):59–71. doi: 10.7326/0003-4819-72-1-59. [DOI] [PubMed] [Google Scholar]
  43. WOODRUFF M. F., NOLAN B., WILSON T. I., ROBSON J. S., LAMBIE A. T., CLARK J. G. HOMOTRANSPLANTATION OF KIDNEY IN PATIENTS TREATED BY PREOPERATIVE LOCAL IRRADIATION AND POSTOPERATIVE ADMINISTRATION OF AN ANTIMETABOLITE (IMURAN). REPORT OF SIX CASES. Lancet. 1963 Sep 28;2(7309):675–682. doi: 10.1016/s0140-6736(63)90465-3. [DOI] [PubMed] [Google Scholar]
  44. Walker W. E., Niblack G. D., Richie R. E., Johnson H. K., Tallent M. B. Use of thoracic duct drainage in human renal transplantation. Surg Forum. 1977;28:316–317. [PubMed] [Google Scholar]
  45. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971 Mar;55(3):283–290. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES